Article citationsMore>>

B. Esmaeli, P. McLaughlin, B. Pro, et al., “Prospective Trial of Targeted Radioimmunotherapy with Y-90 Ibritumomabtiuxetan (Zevalin) for Front-Line Treatment of Early-Stage Extranodal Indolent Ocular Adnexal Lymphoma,” Annals of Oncology, Vol. 20, No. 4, 2009, pp. 709-714. doi:10.1093/ annonc/mdn692

has been cited by the following article: